周二盘前交易中，Inspire Medical Systems（INSP）股价大幅下跌6.14%，主要受到多家知名券商下调其目标价的影响。
根据最新消息，杰富瑞证券将Inspire Medical Systems的目标价从230美元下调至205美元，降幅达10.87%。与此同时，Leerink Partners也对该公司的前景持谨慎态度，将其目标价从194美元下调至176美元，降幅为9.28%。
这些目标价的下调反映了分析师对Inspire Medical Systems未来业绩增长的担忧。投资者对此反应强烈，导致该股在盘前交易中出现大幅跳水。目前尚不清楚具体是哪些因素导致分析师降低了对公司的预期，但这种普遍的悲观情绪无疑对股价造成了显著压力。投资者将密切关注公司未来的财报表现和业务发展，以评估这次股价调整是否合理。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.